The role of preoperative, intratympanic glucocorticoids for hearing preservation in cochlear implantation: A prospective clinical study

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 190-195

  Rajan, Gunesh P ^a   Kuthubutheen, Jafri ^a   Hedne, Naveen ^a   Krishnaswamy, Jay ^a  

^a FREMANTLE HOSPITAL   (Australia)

Author keywords

cochlear implantation; glucocorticoids; hearing preservation; Ontology

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE;

ADULT; AUDITORY STIMULATION; AUDITORY THRESHOLD; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION THERAPY; FEMALE; HEARING LOSS; HEARING PRESERVATION; HUMAN; IMPLANTATION; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW;

AGED; AGED, 80 AND OVER; COCHLEAR IMPLANTATION; DEXAMETHASONE; EAR, MIDDLE; FEMALE; GLUCOCORTICOIDS; HEARING LOSS; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 84255191113     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22142     Document Type: Review

References (26)

1. Podskarbi-Fayette R, Pilka A, Skarzynski H,. Electric stimulation complements functional residual hearing in partial deafness. Acta Oto-Laryngol 2010; 130: 9.
2. Turner CW, Gantz BJ, Karsten S, et al. Impact of hair cell preservation in cochlear implantation: combined electric and acoustic hearing. Otol Neurotol 2010; 31: 6.
3. Kiefer J, Pok M, Adunka O, et al. Combined electric and acoustic stimulation of the auditory system: results of a clinical study. Audiol Neurotol 2005; 10: 11.
4. Gifford RH, Dorman MF, Brown CA,. Psychophysical properties of low-frequency hearing: implications for perceiving speech and music via electric and acoustic stimulation. Adv Otorhinolaryngol 2010; 67: 9.
5. Zhang T, Dorman MF, Spahr AJ,. Information from the voice fundamental frequency (F0) region accounts for the majority of the benefit when acoustic stimulation is added to electric stimulation. Ear Hear 2010; 31: 63-69.
6. Van de water TR, Dinh CT, Vivero R, Hoosien G, Eshraghi AA, Balkany TJ,. Mechanism of hearing loss from trauma and inflammation: Otoprotective therapies from the laboratory to the clinic. Acta Oto-Laryngol 2010; 130: 4.
7. Chandrasekhar SS,. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001; 22: 18-23. (Pubitemid 32182848)
8. Salt AN, Hartsock J, Plontke S, et al. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol Neurootol 2010; 16: 323-335.
9. Mikulec AA, Plontke SK, Hartsock JJ, et al. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 2009; 30: 131-138.
10. Chang A, Eastwood H, Sly D, et al. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009; 255: 67-72.
11. Maini S, Lisnichuk H, Eastwood H, et al. Targeted therapy of the inner ear. Audiol Neurootol 2009; 14: 402-410.
12. van der Laan S, Meijer OC,. Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 2008; 585: 483-491.
13. Nagy I, Caelers A, Monge A, et al. NF-kappaB-dependent apoptotic hair cell death in the auditory system. Audiol Neurootol 2007; 12: 209-220. (Pubitemid 46878918)
14. Salt A,. Guest editorial: drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 2010; 31: 155.
15. Zou J, Zhang W, Poe D, et al. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI. Hear Res 2010; 259: 36-43.
16. Skarzysnki H, Lorens A, Piotrowska A, et al. Preservation of low frequency hearing in partial deafness cochlear implantation (PDCI) using the round window surgical approach. Acta Oto-Laryngol 2007; 127: 9.
17. Eastwood H, Pinder D, James D, et al. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res 2010; 259: 24-30.
18. Huber AM, Hoon SJ, Sharouz B, et al. The influence of a cochlear implant electrode on the mechanical function of the inner ear. Otol Neurotol 2010; 31: 512-518.
19. Hofmann TG, Hehner SP, Bacher S, et al. Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription. FEBS Lett 1998; 441: 441-446. (Pubitemid 29065331)
20. Tabuchi K, Oikawa K, Murshita S, et al. Protective effects of glucocorticoids on ischemia-reperfusion injury of outer hair cells. Laryngoscope 2006; 116: 627-629. (Pubitemid 44318076)
21. Skarzynski H, Lorens A, Piotrowska A, et al. Partial deafness cochlear implantation in children. Int J Pediatr Otorhinolaryngol 2007; 71: 7.
22. Usami S, Moteki H, Suzuki N, et al. Achievement of hearing preservation in the presence of an electrode covering the residual hearing region. Acta Otolaryngol 2011; 131: 405-412.
23. Zhang T, Spahr AJ, Dorman MF,. Frequency overlap between electric and acoustic stimulation and speech-perception benefit in patients with combined electric and acoustic stimulation. Ear Hear 2010; 31: 195-201.
24. Prentiss S, Sykes K, Staecker H,. Partial deafness cochlear implantation at the University of Kansas: techniques and outcomes. J Am Acad Audiol 2010; 21: 197-203.
25. Warchol ME,. Cellular mechanisms of aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 454-458.
26. Musial-Bright L, Fengler R, Henze G, et al. Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma. Childs Nerv Syst 2011; 27: 407-413.